Skip to Content
Search
Home
Markets
Investments
News and Insights
Learn
About
Market Centre
Australia
United States
Europe
Asia
Market Report
ASX Market Report
Roundup of ASX market movements
Global Market Report
Roundup of Global market movements
Market Calendar
Upcoming Dividends
Dividend payments in the coming 90 days
Discover Investments
Investment Ideas
Read the latest investing news and insights
Top Stories
Markets
Personal Finance
Retirement
Stocks
ETFs
Funds
Fixed Income
Industry Insights
Adviser Spotlight
Manager Spotlight
Firstlinks
Investing content
Investing guides
Webinars
Podcasts
Articles
Learn to invest in...
Stocks
Bonds
ETFs/Funds
How to invest
Getting started
Goals based portfolio construction
Portfolio maintenance
Retirement strategies
Our research
Morningstar equity research methodology
Morningstar manager research methodology
Our Solutions
For Advisers
For Licensees & Self-Licensed Practices
For Asset Managers
For Individual Investors
Featured Products and Services
AdviserLogic
Adviser Research Centre
FinaMetrica
Morningstar Direct
Morningstar Investment Management
Licensee Dashboard & CRM
Morningstar Essentials
Morningstar Indexes
Morningstar Data
PayLogic
Morningstar Investor
Sustainalytics
ESG Investing
The Company
Our Story
Our Methodology
Morningstar Investment Conference for Financial Professionals
Morningstar Investment Conference for Individual Investors
Morningstar Adviser Roadshow
Subscribe to our newsletters
Advertise with Us
Careers
Contact Us
Insights
/ Topics / ONCOLOGY
TOPIC
ONCOLOGY News & Analysis
Stocks
2 drugmakers agree to $105bn mega merger
Bristol-Myers Squibb Co says it will buy Celgene Corp for about $105bn, combining two of the world's largest cancer drug businesses in the biggest...
Lex Hall with AAP | 04 January 2019